Journal article Open access Published 2015

A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer

F. Dietlein, B. Kalb, M. Jokic, E.M. Noll, A. Strong, L. Tharun, L. Ozretic, H. Kunstlinger, K. Kambartel, W.J. Randerath, C. Jungst, A. Schmitt, A. Torgovnick, A. Richters, D. Rauh,

Show all 29 authors

F. Siedek, T. Persigehl, C. Mauch, Jiřina Bartkova, A. Bradley, M.R. Sprick, A. Trumpp, R. Rad, D. Saur, Jiří Bártek, J. Wolf, R. Buttner, R.K. Thomas, H.C. Reinhardt

Cell 162(1), 146-159 (2015)

Download PDF View on PubMed Cite

2015 Year
26140595 PMID

Cite this publication

DIETLEIN, F., B. KALB, M. JOKIC, E. NOLL, A. STRONG, L. THARUN, L. OZRETIC, H. KUNSTLINGER, K. KAMBARTEL, W. RANDERATH, C. JUNGST, A. SCHMITT, A. TORGOVNICK, A. RICHTERS, D. RAUH, F. SIEDEK, T. PERSIGEHL, C. MAUCH, J. BARTKOVA, A. BRADLEY, M. SPRICK, A. TRUMPP, R. RAD, D. SAUR, J. BÁRTEK, J. WOLF, R. BUTTNER, R. THOMAS, H. REINHARDT: A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer. Cell. 2015, 162(1), 146-159, ISSN: 0092-8674, PMID: 26140595, PDF.

Cite this publication

Details